Eli Lilly and Company (LLY0) - Financials, balance sheet (quarterly)

17.80000 EUR

0.2

1.14%

Last update May 9, 4:43 PM CEST

Market closed

Day range

17.80000

Previous close

17.60000

Open

Access this stock data via API

Eli Lilly and Company

17.80

0.20

1.14%

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	89.4B	78.7B	75.6B	71.9B
Current assets	41.3B	32.7B	31.4B	30.2B
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.1B	3.3B	3.4B	3.2B
Other short term investments	127.4M	154.8M	149.4M	140.4M
Accounts receivable	12.0B	11.0B	10.3B	11.0B
Other receivables	2.0B	2.3B	1.8B	2.1B
Inventory	9.3B	7.6B	7.5B	6.5B
Prepaid assets	14.7B	8.3B	8.3B	7.1B
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	72.4M	111.4M	134.6M	142.2M
Non current assets	48.1B	46.0B	44.2B	41.7B
Properties	—	11.5B	—	—
Land and improvements	—	382M	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	8.2B	—	—
Leases	—	—	—	—
Accumulated depreciation	-12.1B	-11.8B	-11.8B	-11.4B
Goodwill	17.6B	17.7B	18.1B	18.2B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	6.0B	6.2B	6.5B	6.6B
Investments and advances	3.2B	3.2B	3.2B	2.9B
Other non current assets	14.6B	13.7B	12.5B	11.6B
Total liabilities	73.5B	64.4B	61.3B	58.2B
Current liabilities	30.1B	28.4B	24.7B	27.1B
Accounts payable	3.4B	3.2B	2.9B	2.9B
Accrued expenses	11.6B	11.5B	12.4B	12.4B
Short term debt	4.0B	5.1B	2.1B	5.2B
Deferred revenue	—	—	—	—
Tax payable	6.2B	—	—	—
Pensions	1.1B	2.1B	1.7B	1.2B
Other current liabilities	3.8B	5.1B	5.6B	4.2B
Non current liabilities	43.5B	36.1B	36.6B	31.1B
Long term provisions	—	—	—	—
Long term debt	34.5B	28.5B	29.0B	23.7B
Provision for risks and charges	5.4B	4.1B	3.9B	3.5B
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	2.3B	2.2B	2.2B	2.5B
Shareholders equity
Common stock	592.6M	592.4M	593.9M	594.2M
Retained earnings	15.1B	13.5B	13.6B	13.2B
Other shareholders equity	-3.8B	-4.3B	-4.3B	-4.4B
Total shareholders equity	15.8B	14.3B	14.3B	13.6B
Additional paid in capital	6.9B	7.4B	7.3B	7.2B
Treasury stock	49.5M	49.5M	32.7M	32.7M
Minority interest	82M	79.5M	80.7M	73.5M